Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J A Maitland

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 1, 1986
Bone marrow harvesting for malignant diseaseJ A Maitland, J G Treleaven, H M Clink
Leukemia & Lymphoma|July 27, 2016
Studies on the Clonogenicity of Human Myeloma Cells in vitroB C Millar, J A Maitland, J B Bell, et al.
British Journal of Cancer|May 1, 1989
Melphalan transport into human malignant lymphoid cells differs from the murine equivalent in vitroB C Millar, J A Maitland, J L Millar, et al.
Lancet (London, England)|October 22, 1988
Increase in clonogenic tumour cells in bone marrow of patients with multiple myeloma treated with vincristine, doxorubicin, and methylprednisoloneJ B Bell, B C Millar, J A Maitland, et al.
British Journal of Cancer|March 1, 1990
Evidence that multiple myeloma may be regulated by homeostatic control mechanisms: correlation of changes in the number of clonogenic myeloma cells in vitro with clinical responseJ A Maitland, B C Millar, J B Bell, et al.
British Journal of Haematology|February 1, 1989
In vitro studies of ways to overcome resistance to VAMP--high dose melphalan in the treatment of multiple myelomaB C Millar, J B Bell, J A Maitland, et al.
British Journal of Haematology|July 1, 1990
Colony stimulating activity in the serum of patients with multiple myeloma is enhanced by interleukin 3: a possible role for interleukin 3 after high dose melphalan and autologous bone marrow transplantation for multiple myelomaB C Millar, J B Bell, A Montes, et al.
Lancet (London, England)|October 14, 1989
Intensive treatment of multiple myeloma and criteria for complete remissionM E Gore, P J Selby, C Viner, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 1, 1986
Bone marrow harvesting for malignant diseaseJ A Maitland, J G Treleaven, H M Clink
Leukemia & Lymphoma|July 27, 2016
Studies on the Clonogenicity of Human Myeloma Cells in vitroB C Millar, J A Maitland, J B Bell, et al.
British Journal of Cancer|May 1, 1989
Melphalan transport into human malignant lymphoid cells differs from the murine equivalent in vitroB C Millar, J A Maitland, J L Millar, et al.
Lancet (London, England)|October 22, 1988
Increase in clonogenic tumour cells in bone marrow of patients with multiple myeloma treated with vincristine, doxorubicin, and methylprednisoloneJ B Bell, B C Millar, J A Maitland, et al.
British Journal of Cancer|March 1, 1990
Evidence that multiple myeloma may be regulated by homeostatic control mechanisms: correlation of changes in the number of clonogenic myeloma cells in vitro with clinical responseJ A Maitland, B C Millar, J B Bell, et al.
British Journal of Haematology|February 1, 1989
In vitro studies of ways to overcome resistance to VAMP--high dose melphalan in the treatment of multiple myelomaB C Millar, J B Bell, J A Maitland, et al.
British Journal of Haematology|July 1, 1990
Colony stimulating activity in the serum of patients with multiple myeloma is enhanced by interleukin 3: a possible role for interleukin 3 after high dose melphalan and autologous bone marrow transplantation for multiple myelomaB C Millar, J B Bell, A Montes, et al.
Lancet (London, England)|October 14, 1989
Intensive treatment of multiple myeloma and criteria for complete remissionM E Gore, P J Selby, C Viner, et al.
Pageof 1